App analytics data were captured to examine Moodivate feasibility (analytics unavailable for control app). Participants completed assessments of depressive symptoms weekly for eight weeks. Participants (N = 52) were recruited from primary care practices between January and December 2017 and were randomized 2:2:1 to receive: 1) Moodivate, 2) an active control Cognitive Behavioral Therapy-based mobile app (“MoodKit”), or 3) Treatment As Usual (TAU no app). The purpose of the present study was to preliminarily examine the feasibility and efficacy of a self-help Brief Behavioral Activation mobile application (app “Moodivate”) for depressive symptoms among adults treated via primary care. Mobile technologies can be leveraged to meet the need for evidence-based psychological depression treatment via primary care.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |